25 Feb 2019
Permanent polymer zotarolimus vs. polymer-free amphilimus stent: ReCre8 Trial
EuroIntervention Journal
Consult this randomised trial which compares the clinical safety and efficacy of polymer-free amphilimus-eluting stents (PF-AES) with permanent-polymer zotarolimus-eluting stents (PP-ZES)
This physician-initiated, prospective multicentre, randomised non-inferiority trial, evaluates target lesion failure in cardiac death, target-vessel MI or target-lesion revascularisation at 12 months.
